Latest Health News from Duke Medicine News and Communications
Clinical Trial Sponsors Fail to Report Results to Participants, Public
Mar. 11, 2015
Despite legal and ethical mandates for disclosure, results from most clinical trials of medical products are not reported promptly on a registry specifically created to make results of human studies publically available, according to Duke Medicine researchers.
Lisanby To Lead Division At National Institute of Mental Health
Mar. 4, 2015
Sarah H. Lisanby, M.D., chair of the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine and an internationally known researcher in the treatment of major depression, has been named director of the Division of Translational Research at the National Institute of Mental Health (NIMH).
Change in Medicare Fee Linked to Rise of Vascular Treatment
Mar. 4, 2015
Federal efforts to curb Medicare costs for unclogging blood vessels in the limbs slowed the growing use of the treatments, but also coincided with a marked increase in doctors using a more expensive approach, according to an analysis by Duke Medicine researchers.
Investigational Therapy Could Attack Cause of Sickle Cell Crises
Mar. 2, 2015
Treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, known as vaso-occlusion crises, researchers at Duke Medicine report.
Guidelines Suggest Blood Thinners For More Women, Seniors
Mar. 2, 2015
Nearly all women and people over 65 in the U.S. with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute.
Retinal Swelling in Premature Infants Tied to Poorer Neuro-Development
Feb. 24, 2015
Using a portable, non-invasive imaging device, a team of Duke Medicine doctors have identified swelling in the back of the eyes of premature infants that correlates with poorer neurodevelopment as the babies grow.
Duke Awarded $10.4 Million Contract To Continue Developing Radiation Test
Feb. 17, 2015
In the event of nuclear meltdown or improvised nuclear bomb, presumed victims of radiation exposure would overwhelm emergency responders and hospitals. Victims can’t smell or see radiation around them, and low-level exposure doesn’t result in obvious bodily injury. The likely outcome: long lines of patients with no visual symptoms, panicked and difficult to assess.
Gene Mutation Drives Cartilage Tumor Formation
Feb. 16, 2015
Duke Medicine researchers have shown how gene mutations may cause common forms of cartilage tumors.
Newly Discovered Protein Has Link to Gestational Diabetes
Feb. 4, 2015
For at least 40 years, scientists who study how the body metabolizes sugar have accepted one point: there are four enzymes that kick-start the body’s process of getting energy from food.
Duke’s Robert Califf Named as Deputy FDA Commissioner
Jan. 26, 2015
Robert Califf, M.D., vice chancellor of clinical and translational research at Duke University School of Medicine and a global leader in cardiovascular medicine, clinical and translational research and medical economics, has been named deputy commissioner for Medical Products and Tobacco at the Food and Drug Administration.